E-cadherin is a known TBX3 target [20] and its expression has been shown to be inhibited by the AKT pathway in melanoma cells [19] suggesting that AKT-induced phosphorylation of TBX3 may be required to inhibit E-cadherin levels in these cells. The gene discussed is AKT1; the disease is melanoma.